# Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection

> **NCT04332848** · PHASE4 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 360 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** ET
- **DRUG:** SGT

## Key facts

- **NCT ID:** NCT04332848
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-28
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04332848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04332848, "Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04332848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*